| Primary |
| Renal Cancer |
45.4% |
| Renal Cell Carcinoma |
18.0% |
| Metastatic Renal Cell Carcinoma |
8.0% |
| Hypertension |
4.0% |
| Malignant Urinary Tract Neoplasm |
3.5% |
| Neoplasm Malignant |
3.2% |
| Pain |
3.1% |
| Renal Cancer Metastatic |
3.1% |
| Kidney Cancer |
1.3% |
| Nausea |
1.3% |
| Carcinoma Kidney |
1.2% |
| Malignant Neoplasm Of Renal Pelvis |
1.1% |
| Constipation |
1.0% |
| Cancer Pain |
0.9% |
| Metastases To Bone |
0.9% |
| Gastritis |
0.8% |
| Hypothyroidism |
0.8% |
| Diabetes Mellitus |
0.8% |
| Malignant Neoplasm Of Kidney, Except Pelvis |
0.8% |
| Insomnia |
0.7% |
|
| Death |
26.6% |
| Renal Cancer |
16.1% |
| Weight Decreased |
5.7% |
| Renal Cell Carcinoma |
5.5% |
| Diarrhoea |
5.1% |
| Hypertension |
4.3% |
| Vomiting |
4.1% |
| Nausea |
3.9% |
| Neoplasm Malignant |
3.6% |
| Stomatitis |
3.6% |
| Fatigue |
3.2% |
| Metastatic Renal Cell Carcinoma |
2.7% |
| Pain In Extremity |
2.7% |
| Dysphonia |
2.6% |
| Off Label Use |
2.1% |
| Disease Progression |
1.9% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
1.6% |
| Rash |
1.6% |
| Headache |
1.5% |
| Malaise |
1.5% |
|
| Secondary |
| Renal Cancer |
31.3% |
| Renal Cell Carcinoma |
18.7% |
| Metastatic Renal Cell Carcinoma |
9.5% |
| Hypertension |
7.0% |
| Pain |
6.2% |
| Malignant Urinary Tract Neoplasm |
3.7% |
| Nausea |
2.9% |
| Gastritis |
2.4% |
| Dyspnoea |
2.2% |
| Cancer Pain |
2.0% |
| Convulsion |
1.6% |
| Leukaemia |
1.6% |
| Prostatomegaly |
1.6% |
| Sinus Disorder |
1.6% |
| Constipation |
1.3% |
| Depression |
1.3% |
| Metastases To Bone |
1.3% |
| Product Used For Unknown Indication |
1.3% |
| Renal Cancer Stage Iv |
1.3% |
| Hypothyroidism |
1.1% |
|
| Weight Decreased |
18.6% |
| Death |
10.4% |
| Stomatitis |
10.0% |
| Renal Cancer |
8.6% |
| Pain In Extremity |
6.8% |
| Vomiting |
6.3% |
| Hypertension |
4.5% |
| Renal Cell Carcinoma |
4.5% |
| Nausea |
3.6% |
| Weight Increased |
3.6% |
| Metastatic Renal Cell Carcinoma |
3.2% |
| Diarrhoea |
2.7% |
| Off Label Use |
2.7% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.7% |
| Pneumonia |
2.7% |
| Drug Intolerance |
2.3% |
| Dizziness |
1.8% |
| Dysphonia |
1.8% |
| Fatigue |
1.8% |
| Convulsion |
1.4% |
|
| Concomitant |
| Hypertension |
20.0% |
| Renal Cancer |
20.0% |
| Gastric Ulcer |
6.7% |
| Lumbar Spinal Stenosis |
6.7% |
| Malignant Urinary Tract Neoplasm |
6.7% |
| Metastases To Bone |
6.7% |
| Metastatic Renal Cell Carcinoma |
6.7% |
| Pain |
6.7% |
| Renal Cell Carcinoma |
6.7% |
| Renal Neoplasia |
6.7% |
| Rhinitis Allergic |
6.7% |
|
| Disease Progression |
12.5% |
| Hypocalcaemia |
12.5% |
| Osteonecrosis Of Jaw |
12.5% |
| Pyrexia |
12.5% |
| Renal Cell Carcinoma |
12.5% |
| Toxicity To Various Agents |
12.5% |
| Treatment Failure |
12.5% |
| Vomiting |
12.5% |
|
| Interacting |
| Arrhythmia |
24.0% |
| Blood Pressure |
24.0% |
| Dyspepsia |
8.0% |
| Metastatic Renal Cell Carcinoma |
8.0% |
| Product Used For Unknown Indication |
8.0% |
| Renal Cell Carcinoma |
8.0% |
| Seizures |
8.0% |
| Agitation |
4.0% |
| Anxiety |
4.0% |
| Renal Neoplasm |
4.0% |
|
| Vomiting |
33.3% |
| Weight Decreased |
33.3% |
| Agitation |
16.7% |
| Stomatitis |
16.7% |
|
